Trial Profile
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Allergan
- 12 Jul 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 22 Jun 2017 New trial record